1.The Comparison of Health Behaviors, Use of Health Services, and Health Expenditures among Diabetic Patients according to the Practice of Exercise.
Journal of Korean Academy of Community Health Nursing 2015;26(1):31-41
PURPOSE: The purpose of this study was to compare the use of health services and health expenditures between non-exercise and exercise groups of diabetic patients and among three groups divided according to exercise intensity. METHODS: Data were obtained from the Korean Health Panel Survey of 2011. The participants of this study were 864 diabetic patients who did exercise (walk, moderate exercise, or vigorous exercise) or not. Data were subsequently analyzed using the SPSS 21 Program. RESULTS: The exercise group showed higher percentages of medication compliance, non-smokers, and regular diet than the non-exercise group. The hospitalization percentage, the number of outpatient hospital visits, and health expenditures were higher in the non-exercise group than in the exercise group. There was no difference among the three groups divided according to exercise intensity in the use of health services and health expenditures. CONCLUSION: These results show that exercise is a way to reduce diabetic patients' use of health services and their health expenditures.
Diabetes Mellitus
;
Diet
;
Health Behavior*
;
Health Expenditures*
;
Health Services*
;
Hospitalization
;
Humans
;
Medication Adherence
;
Outpatients
2.Multifocal Polypoid Endometriosis Mimicking Malignancy in a Young Woman with a History of Hormonal Treatment.
Ji Young KIM ; Tae Jong SONG ; Hye Kyung CHOI ; Jeong Yun SHIM
Journal of Pathology and Translational Medicine 2015;49(5):418-420
No abstract available.
Endometriosis*
;
Female
;
Humans
3.Analysis of Important Medical Adverse Events and Signals Related with Cyclosporine and Tacrolimus Using the FDA Adverse Event Reporting System (FAERS) Database
Seung Hyeon CHA ; Ji Hyeon IM ; Yun-Kyoung SONG
Korean Journal of Clinical Pharmacy 2022;32(4):352-361
Objective:
This study aimed to analyze the important medical adverse events (IMEs) of cyclosporine and tacrolimus using the reports in US FDA adverse event reporting system (FAERS) and to detect related signals.
Methods:
The FAERS database was used to analyze the IMEs reported for cyclosporine or tacrolimus during 2017-2021. Reporting odds ratio (ROR) and information component were used to analyze signals for adverse events of both drugs. It was investigated whether the detected signals were present on drug labels in Korea and the United States.
Results:
Among the total 24,688 reports, the reports on tacrolimus accounted 75.8%. Mean age of the patients was 47.9 years old and median number of adverse events was 2.0 per report. The number of patients hospitalized for adverse events was 7,979 (25.3%). Among the adverse reactions reported on the cyclosporine and tacrolimus, 576 and 1,363 events were detected as signals for cyclosporine and tacrolimus, respectively, and of these, IMEs accounted for 44.8 and 59.2%, respectively. The IMEs related with infections/infestations, renal/urinary disorders, and blood and lymphatic system disorders were reported frequently for both drugs. The most frequently detected IMEs were renal impairment for cyclosporine and acute kidney injury for tacrolimus. Among the top 3 IMEs for each reported SOC for cyclosporine and tacrolimus, 9 and 2 unexpected adverse events were identified, respectively.
Conclusion
This study identified the IMEs and signals of cyclosporine and tacrolimus, and detected unidentified adverse events in a drug information database.
4.Impact of the Ventricle Size on Alzheimer’s Disease Progression:A Retrospective Longitudinal Study
Ji-seon LEE ; Do-yun HEO ; Kyung-Hae CHOI ; Hee-Jin KIM
Dementia and Neurocognitive Disorders 2024;23(2):95-106
Background:
and Purpose: Ventricle enlargement has been implicated in the pathophysiology of Alzheimer’s disease (AD). We studied the relationship between ventricular size and cognitive function in patients with AD. We focused on the effect of the initial ventricle size on the rate of cognitive decline in patients with AD.
Methods:
A retrospective analysis of probable clinical AD participants with more than 2 magnetic resonance imaging images was performed. To measure ventricle size, we used visual rating scales of (1) Cardiovascular Health Study (CHS) score and (2) conventional linear measurement method.
Results:
Increased clinical dementia rating (CDR) was correlated with a decreased MiniMental Status Examination (MMSE) score, and increased medial temporal lobe atrophy (MTLA) and global ventricle size (p<0.001, p<0.001, p=0.021, respectively). There was a significant correlation between the change in cognitive function in the group (70%–100%ile) with a large initial ventricle size (p=0.021 for ΔCDR, p=0.01 for ΔMMSE), while the median ventricle size (30%–70%ile) showed correlation with other brain structural changes (MTLA, frontal atrophy [FA], and white matter) (p=0.036 for initial MTLA, p=0.034 for FA).
Conclusions
In this study, the initial ventricle size may be a potential new imaging biomarker for initial cognitive function and clinical progression in AD. We found a relationship between the initial ventricle size and initial AD-related brain structural biomarkers.
5.Splenic Infarction as the Initial Manifestation of Antiphospholipid Syndrome in a Systemic Lupus Erythematosus Patient.
Hye Yun JEONG ; San Ha KANG ; Ji Hyun SONG ; Sun Young SHIN ; Daniel MIN ; Kyu Hyun HAN ; Jin Jung CHOI
Korean Journal of Medicine 2014;86(5):651-654
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. In patients with SLE, the prevalence of antiphospholipid antibodies is considerably higher, and is largely responsible for thrombosis. Splenic infarction is a rare complication of arterial thrombosis in patients with SLE. It is important to consider splenic infarction in a patient with SLE complaining of left upper quadrant (LUQ) pain because of the possibility of severe infarction-related complications, such as subcapsular hemorrhage and splenic rupture. We report a case of solitary splenic infarction in a patient with SLE. The only symptom was LUQ pain of 3-day duration. Lupus anticoagulant activity was positive and abdominal-pelvic computed tomography (CT) was consistent with splenic infarction. She did not show any other evidence of thrombotic events. The patient was diagnosed with antiphospholipid syndrome that presented as a splenic infarction in a SLE patient.
Antibodies, Antiphospholipid
;
Antiphospholipid Syndrome*
;
Autoimmune Diseases
;
Hemorrhage
;
Humans
;
Lupus Coagulation Inhibitor
;
Lupus Erythematosus, Systemic*
;
Prevalence
;
Splenic Infarction*
;
Splenic Rupture
;
Thrombosis
6.Apocrine Carcinoma of the Breast: A Case Report.
Do Youn KIM ; Seok Seon KANG ; Hwa Young KIM ; Eun Kyung JI ; Tae Hee KWON ; Hai Lin PARK ; Jeong Yun SHIM
Journal of the Korean Radiological Society 2007;57(2):203-206
Apocrine carcinoma is a rare breast cancer and its frequency is about 0.4% of all breast cancers. Little is known about its clinical behavior and prognosis. To our knowledge, few studies have reported the radiologic appearances of apocrine carcinoma in the breast and there has been no such report from Korea. We describe the sonographic findings of a case of apocrine carcinoma in the breast. The sonographic findings are microlobulated heterogeneous hypoechoic lesion that has a central markedly hypoechoic portion and a peripheral mixture of iso and hypoechgenecity.
Apocrine Glands
;
Breast Neoplasms
;
Breast*
;
Korea
;
Prognosis
;
Ultrasonography
7.Is Mammotome Excision Feasible for Benign Breast Mass Bigger than 3 cm in Greatest Dimension?.
Hai Lin PARK ; Jin Young KWAK ; Haekyong JUNG ; Seung Hee LEE ; Jeong Yun SHIM ; Ji Young KIM ; Kyung Sik LEE
Journal of the Korean Surgical Society 2006;70(1):25-29
PURPOSE: The aim of this study was to evaluate that a surgeon can safely remove all sonographic evidence of masses in the breast grater than 3.0 cm in greatest dimension using the 8 g hand held Mammotome (MT). METHODS: From Jan. 2003 to Mar. 2005, a total of 1,368 US-guided MT excision were performed in 1,112 patients at Kangnam Cha hospital. Of these 1,368 lesions 28 lesions with BI-RADS category 3 features by ultrasonography were included in this study. Ultrasonographic follow-up were performed on 3~6 months later to assess residual tissue and scarring. RESULTS: Mean patient age was 32.0 years (range 20~55 years). The average size of lesion was 3.5 cm (SD+-0.43 cm). All of the lesions were palpable and all of the specimens were benign. Most common pathologic features were fibroadenoma (75.0%) and breast abscess (14.3%). Mean time required to perform mammotome procedures was 12.2+/-8.2 minutes and mean number of cores removed were 35.1+/-30.2 pieces. No bleeding or infections occurred postoperatively and most complications were mild and anticipated. CONCLUSION: This study demonstrates that percutaneous removal of big breast benign mass above 3 cm in diameter using The MT system is feasible, effective and safe method for the therapeutic management with minimal morbidity without any additional procedures.
Abscess
;
Breast*
;
Cicatrix
;
Fibroadenoma
;
Follow-Up Studies
;
Hand
;
Hemorrhage
;
Humans
;
Ultrasonography
8.Incidental ipsilateral subclavian vein catheterization via right internal jugular venous route: A case report.
Minsung KIM ; Jong yeon LEE ; Wan Seop YUN ; Chung Hyun PARK ; Ji Eun SONG ; Seok Hwan CHOI
Anesthesia and Pain Medicine 2012;7(1):38-40
Central venous catheterization is frequently performed for perioperative management and intravenous access. However, the complications of central venous catheterization are numerous and include malposition, pneumothorax, hemothorax, chylothorax, thrombosis, extravasation of the infusate and infection. Although the malpositioning of the central venous catheter has been widely reported, there are few reports of ipsilateral subclavian vein catheterization via the right internal jugular venous route. In this case, we describe a misplacement of a right internal venous catheterization into the ipsilateral subclavian vein and suggest the possible causative factors.
Catheterization
;
Catheterization, Central Venous
;
Catheters
;
Central Venous Catheters
;
Chylothorax
;
Hemothorax
;
Pneumothorax
;
Subclavian Vein
;
Thrombosis
9.Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Min Jin LEE ; Bo Seong YUN ; Seok Ju SEONG ; Mi La KIM ; Yong Wook JUNG ; Mi Kyoung KIM ; Hyo Sook BAE ; Da Hee KIM ; Ji Young HWANG
Obstetrics & Gynecology Science 2017;60(1):69-73
OBJECTIVE: The aim of this study was to evaluate the effect of short-term use of selective progesterone receptor modulator (SPRM) or gonadotropin-releasing hormone (GnRH) agonist on uterine fibroid shrinkage among Korean women. METHODS: This retrospective study involved 101 women with symptomatic uterine fibroids who received ulipristal acetate (SPRM, n=51) and leuprolide acetate (GnRH agonist, n=50) for 3 months between November 2013 and February 2015. The fibroid volume was measured both before and after treatment using ultrasonography, computed tomography, and magnetic resonance imaging. The outcomes were compared between the SPRM and GnRH agonist groups. RESULTS: The median rate of fibroid volume reduction after SPRM treatment was 12.4% (IQR −14.5% to 40.5%) which was significantly lower than the reduction rate observed after GnRH agonist treatment (median 34.9%, IQR 14.7% to 48.6%, P=0.004). 19 of 51 (37.3%) patients with SPRM treatment did not show any response of volume shrinkage, while 7 of 50 (14.0%) women with GnRH agonist showed no response (P=0.007). CONCLUSION: Short-term SPRM treatment yields lower volume reduction than GnRH agonist treatment in Korean women with symptomatic fibroids. Further large-scale randomized trials are needed to confirm our findings.
Female
;
Gonadotropin-Releasing Hormone*
;
Humans
;
Leiomyoma*
;
Leuprolide
;
Magnetic Resonance Imaging
;
Progesterone*
;
Receptors, Progesterone*
;
Retrospective Studies
;
Ultrasonography
10.General anesthesia for cesarean section in a patient with multiple sclerosis: A case report.
Yun Sic BANG ; Kum Hee CHUNG ; Seok Hwan CHOI ; Duk Hee CHUN ; Minsung KIM ; Hyeonjeong YANG ; Ji Eun SONG ; Jong Yeon LEE
Anesthesia and Pain Medicine 2012;7(2):178-180
A 34-year-old female with multiple sclerosis (MS) was scheduled Cesarean section. She had been suffering from MS for 10 years and the symptoms of MS were paraplegia and urinary incontinence. After informed consent, anesthesia was induced with propofol and maintained with nitrous oxide, sevoflurane and fentanyl. Rocuronium was used for muscle relaxation and tracheal intubation. Train of four (TOF) ratio and bispectral index scale were monitored for adequate muscle relaxation and depth of anesthesia. She gave birth to a baby within 7 minutes after skin incision. When operation was over, TOF ratio was 0.8. She emerged from general anesthesia smoothly and was extubated. There was no febrile event or exacerbation of MS after Cesarean section under general anesthesia. We report a safe anesthetic management of the parturient with MS, using sevoflurane.
Adult
;
Androstanols
;
Anesthesia
;
Anesthesia, General
;
Cesarean Section
;
Female
;
Fentanyl
;
Humans
;
Informed Consent
;
Intubation
;
Methyl Ethers
;
Multiple Sclerosis
;
Muscle Relaxation
;
Nitrous Oxide
;
Paraplegia
;
Parturition
;
Pregnancy
;
Propofol
;
Skin
;
Stress, Psychological
;
Urinary Incontinence